[1]Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2024, 74(3): 229-263.
[2]Lee Y C, Chiang T H, Chiu H M, et al. Screening for Helicobacter pylori to prevent gastric cancer: a pragmatic randomized clinical trial[J]. JAMA, 2024, 332(19): 1642-1651.
[3]Qiu M Z, Oh D Y, Kato K, et al. Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma:RATIONALE-305 randomised,double blind,phase 3 trial[J]. BMJ, 2024, 385: e078876.
[4]Chen Y C, Malfertheiner P, Yu H T, et al. Global prevalence of Helicobacter pylori infection and incidence of gastric cancer between 1980 and 2022[J]. Gastroenterology, 2024, 166(4): 605-619.
[5]Wizenty J, Sigal M. Helicobacter pylori, microbiota and gastric cancer-principles of microorganism-driven carcinogenesis[J]. Nat Rev Gastroenterol Hepatol, 2025: 22(5): 296-313.
[6]Gao Y, Tan D S, Girbig M, et al. The emergence of Sox and POU transcription factors predates the origins of animal stem cells[J]. Nat Commun, 2024, 15(1): 9868.
[7]Angelozzi M, Karvande A, Lefebvre V. SOXC are critical regulators of adult bone mass[J]. Nat Commun, 2024, 15(1): 2956.
[8]Wang S H, Zhu X, Hao Y, et al. ALKBH5-mediated m6A modification of circFOXP1 promotes gastric cancer progression by regulating SOX4 expression and sponging miR-338-3p[J]. Commun Biol, 2024, 7(1): 565.
[9]Mülder D T, Hahn A I, Huang R J, et al. Prevalence of gastric precursor lesions in countries with differential gastric cancer burden: a systematic review and meta-analysis[J]. Clin Gastroenterol Hepatol, 2024, 22(8): 1605-1617, e46.
[10]Zeng R J, Gou H Y, Lau H C H, et al. Stomach microbiota in gastric cancer development and clinical implications[J]. Gut, 2024, 73(12): 2062-2073.
[11]Baldan J, Camacho-Roda J, Ballester M, et al. Resolution of acinar dedifferentiation regulates tissue remodeling in pancreatic injury and cancer initiation[J]. Gastroenterology, 2024, 167(4): 718-732, e18.
[12]Anon. Shaping a nature reviews cancer article[J]. Nat Rev Cancer, 2019, 19(3): 121.
[13]Aryal S, Lu R. HOXA9 regulome and pharmacological interventions in leukemia[J]. Adv Exp Med Biol, 2024, 1459: 405-430.
[14]Wang X W, Wu Y, Wang D, et al. MicroRNA network analysis identifies key microRNAs and genes associated with precancerous lesions of gastric cancer[J]. Genet Mol Res, 2014, 13(4): 8695-8703.
[15]Ai C, Huang Z H, Rong T H, et al. The impact of SOX4-activated CTHRC1 transcriptional activity regulating DNA damage repair on cisplatin resistance in lung adenocarcinoma[J]. Electrophoresis, 2024, 45(15/16): 1408-1417.
[16]Pan X, Zhao J, Zhang W N, et al. Induction of SOX4 by DNA damage is critical for p53 stabilization and function[J]. Proc Natl Acad Sci U S A, 2009, 106(10): 3788-3793.
[17]Drflinger B, Badr M T, Haimovici A, et al. Mitochondria supply sub-lethal signals for cytokine secretion and DNA-damage in H.pylori infection[J]. Cell Death Differ, 2022, 29(11): 2218-2232.
[18]He J Z, Nascakova Z, Leary P, et al. Inactivation of the tumor suppressor gene Apc synergizes with H.pylori to induce DNA damage in murine gastric stem and progenitor cells[J]. Sci Adv, 2023, 9(46): eadh0322.
[19]Ha Thi H T, Kim H Y, Kim Y M, et al. MicroRNA-130a modulates a radiosensitivity of rectal cancer by targeting SOX4[J]. Neoplasia, 2019, 21(9): 882-892.
|